Cite
HARVARD Citation
Jang, W. et al. (n.d.). Anti‐tumor activity of WK88‐1, a novel geldanamycin derivative, in gefitinib‐resistant non‐small cell lung cancers with Met amplification. Cancer science. 105 (10), pp. 1245-1253. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jang, W. et al. (n.d.). Anti‐tumor activity of WK88‐1, a novel geldanamycin derivative, in gefitinib‐resistant non‐small cell lung cancers with Met amplification. Cancer science. 105 (10), pp. 1245-1253. [Online].